Theratechnologies (TH) Stock Statistics & Valuation Metrics

Theratechnologies has a market cap or net worth of ―. The enterprise value is ―.

Theratechnologies has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Theratechnologies’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 52.94%.

The current PE Ratio of Theratechnologies is ―. Theratechnologies’s PEG ratio is ―.

In the last 12 months, Theratechnologies had revenue of 85.87M and earned -8.31M in profits. Earnings per share was -0.17.

In the last 12 months, operating cash flow was 7.04M and capital expenditures -10.11M, giving a free cash flow of -3.08M billion.

Theratechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

Theratechnologies upcoming earnings date is Oct 9, 2025, TBA (Confirmed).

Theratechnologies as a current ratio of 1.19, with Debt / Equity ratio of -156.22%

In the past 12 months, Theratechnologies has paid 2.00M in taxes.

Theratechnologies EV to EBITDA ratio is 14.48, with an EV/FCF ratio of 113.29.

Theratechnologies has $9.92M in cash and marketable securities with ― in debt, giving a net cash position of -$33.70M billion.

Gross margin is 77.72%, with operating margin of 9.52%, and net profit margin of -9.67%.

The average price target for Theratechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―